Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Tianshan Bio(300313) the Revenue is 101.03 M (+495.6%);the EBIT is 3.144 M (+740.1%);the EPS is 0.0003 (+103%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.10B495.59%
----
----
EBIT
0.00B740.12%
----
----
EPS
0.0003103.02%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf